Tizanidine Tablets — Class II drug recall D-0223-2024
Completed recall by Dr. Reddy's Laboratories, Inc., reported 2024-01-17, distributed nationwide. Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
| Recall number | D-0223-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Dr. Reddy's Laboratories, Inc., Princeton, NJ, United States |
| Recall initiated | 2024-01-02 |
| Classified | 2024-01-11 |
| Reported by FDA | 2024-01-17 |
| Distributed | Nationwide (US) |
| Quantity | 38,952 bottles |
| NDC | 55111-0179, 55111-0179-03, 55111-0179-10, 55111-0179-15, 55111-0179-30, 55111-0180, 55111-0180-03, 55111-0180-10, 55111-0180-15, 55111-0180-30 |
| Lot numbers | T2304007 |
| Expiration dates | 2026-07-31 |
Product
Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15
Reason for recall
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0223-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.